MedTrace Logo

Covid-19 in Hematological Malignancies

NCT04733729 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-05-29

No results posted yet for this study

Summary

The overall purpose of this project is to better understand the epidemiology of COVID-19 in patients with hematological malignancies (including hematopoietic stem cell transplant recipients) in the different European Countries. The results obtained will allow us to better know the prevalence of this complication in the different categories of patients with hematological malignancies (HMs). In order to attain the objectives previously described we will develop a multicentre, international, observational, retrospective and prospective study of consecutive cases of COVID-19 among HMs. There will be a clinical follow-up of the patients included in this study to observe the survival rate. Data collected form this study will be evaluated with a descriptive analysis.

Conditions

  • COVID-19 Infection in Hematological Malignancies Patients

Sponsors & Collaborators

  • European Hematology Association

    collaborator UNKNOWN

  • Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2022-09-30
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04733729 on ClinicalTrials.gov